Biomark Diagnostics Inc. (CSE:BUX)
Canada · Delayed Price · Currency is CAD 0.5000
0.00 (0.00%)
At close: Feb 9, 2026
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of CAD 48.56 million as of February 9, 2026. Its market cap has increased by 192.31% in one year.
Market Cap
48.56M
Enterprise Value
47.82M
Revenue
123.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 40.39M to 48.56M, an increase of 20.24%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 48.78M | -6.98% |
| Dec 30, 2025 | 52.44M | 254.54% |
| Dec 30, 2024 | 14.79M | -17.24% |
| Dec 29, 2023 | 17.87M | 24.67% |
| Dec 30, 2022 | 14.34M | -23.96% |
| Dec 30, 2021 | 18.85M | 116.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spectral Medical | 380.33M |
| Sona Nanotech | 44.61M |
| Izotropic | 15.23M |
| Avricore Health | 7.09M |
| Leveljump Healthcare | 6.27M |
| Telo Genomics | 4.52M |
| ARCpoint | 1.28M |
| Justera Health | 1.24M |